Skip to main content
UniHealth

Doctor search

Fengdan Wang, MD

Internal Medicine · Mountain View

NPI 1366716391

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
1
1 carrier
Offices
2

Offices

2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plans that list them

1 plan · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A132936 · Current

Licensed to practise in California · since 2014 · expires 2028-10-31 · Shenyang Medical College.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$32,112

Pharmacies billed $32,112 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (11 of 1,175) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.

1,110 generic and fewer than 11 brand-name prescriptions · $32,112 in drug cost · 26 antibiotic prescriptions to 21 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Alvesco17$1,592$94
Atorvastatin136$1,530$11
Amlodipine Besylate103$1,302$13
Levothyroxine63$1,068$17
Losartan83$1,029$12
See all 25 drugs
Every Part D drug this clinician prescribed
Alvesco17$1,592$94
Atorvastatin136$1,530$11
Amlodipine Besylate103$1,302$13
Levothyroxine63$1,068$17
Losartan83$1,029$12
Diltiazem 12hr Er11$1,010$92
Lisinopril52$655$13
Atenolol44$543$12
Gabapentin21$499$24
Alendronate41$402$10
Metformin30$386$13
Potassium Chloride13$358$28
Fluticasone Propionate19$352$19
Pantoprazole29$290$10
Simvastatin23$259$11
Hydrochlorothiazide21$235$11
Trazodone25$198$8
Metoprolol21$182$9
Glipizide16$180$11
Rosuvastatin15$175$12
Lovastatin13$152$12
Furosemide18$138$8
Tamsulosin11$132$12
Ondansetron13$122$9
Losartan-Hydrochlorothiazide11$122$11

Year by year

Part D prescribing by year
20241,1752501% (11)None$32,112
20231,125226NoneNone$34,531
20221,1282285% (54)None$39,868
20211,0962382% (18)10%$80,680
20209101792% (19)11%$38,395
20196921302% (16)14%$37,811
20188121453% (20)None$26,095
20175861303% (18)19%$20,838
20162201006% (13)None$10,869
20159725None29%$7,041
201419936None40%$21,120
201321130None30%$11,239

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 22 drugs

Part D drugs prescribed in 2023
Atorvastatin131$1,706$13
Amlodipine Besylate111$1,407$13
Alvesco16$1,405$88
Levothyroxine59$1,258$21
Losartan77$982$13
Ondansetron12$652$54
Lisinopril46$597$13
Atenolol45$597$13
Metformin38$478$13
Albuterol Sulfate Hfa17$357$21
Alendronate31$319$10
Hydrochlorothiazide27$304$11
Pantoprazole21$242$12
Hydralazine11$240$22
Glipizide21$229$11
Rosuvastatin15$225$15
Famotidine18$210$12
Simvastatin17$198$12
Metoprolol18$164$9
Trazodone21$164$8
Losartan-Hydrochlorothiazide11$128$12
Metformin Hcl Er12$111$9

2022: 24 drugs

Part D drugs prescribed in 2022
Levothyroxine61$1,332$22
Atorvastatin107$1,261$12
Losartan71$948$13
Amlodipine Besylate79$929$12
Gabapentin32$537$17
Metformin39$485$12
Tramadol47$453$10
Atenolol36$423$12
Albuterol Sulfate Hfa20$415$21
Lisinopril33$409$12
Potassium Chloride12$356$30
Losartan-Hydrochlorothiazide12$346$29
Alendronate32$333$10
Pantoprazole20$251$13
Glipizide21$248$12
Fluticasone Propionate17$225$13
Simvastatin18$210$12
Triamcinolone Acetonide12$177$15
Metoprolol19$171$9
Trazodone20$161$8
Hydrochlorothiazide13$152$12
Famotidine11$151$14
Furosemide13$151$12
Lovastatin11$128$12

2021: 25 drugs

Part D drugs prescribed in 2021
Wixela Inhub19$2,190$115
Alvesco16$1,727$108
Levothyroxine60$1,392$23
Atorvastatin92$1,079$12
Losartan78$997$13
Amlodipine Besylate80$939$12
Metformin38$500$13
Atenolol47$494$11
Losartan-Hydrochlorothiazide14$447$32
Lisinopril32$389$12
Pantoprazole27$362$13
Alendronate35$360$10
Albuterol Sulfate Hfa15$334$22
Hydrochlorothiazide26$294$11
Fluticasone Propionate21$271$13
Gabapentin12$253$21
Glipizide20$233$12
Tamsulosin11$215$20
Simvastatin17$194$11
Metoprolol19$173$9
Lovastatin14$163$12
Furosemide16$151$9
Tizanidine12$132$11
Lisinopril-Hydrochlorothiazide11$109$10
Metformin Hcl Er11$86$8

2020: 23 drugs

Part D drugs prescribed in 2020
Lantus Solostar16$9,523$595
Invokana11$6,299$573
Humulin N15$2,713$181
Levothyroxine56$1,599$29
Atorvastatin75$973$13
Losartan65$793$12
Amlodipine Besylate65$745$11
Metformin36$460$13
Lisinopril30$339$11
Pantoprazole26$330$13
Alendronate29$302$10
Hydrochlorothiazide26$299$11
Gabapentin13$245$19
Atenolol25$232$9
Glipizide20$230$11
Simvastatin17$194$11
Metoprolol19$158$8
Lovastatin12$149$12
Fluticasone Propionate11$146$13
Trazodone14$141$10
Metformin Hcl Er12$125$10
Cephalexin12$124$10
Tramadol15$122$8

2019: 18 drugs

Part D drugs prescribed in 2019
Invokana19$10,528$554
Lantus Solostar14$5,859$419
Atorvastatin58$1,196$21
Levothyroxine37$1,072$29
Diclofenac11$1,032$94
Losartan63$725$12
Ventolin Hfa14$673$48
Klor-Con M2014$533$38
Amlodipine Besylate46$507$11
Metformin25$309$12
Lovastatin20$281$14
Lisinopril26$269$10
Atenolol18$256$14
Fluticasone Propionate18$232$13
Hydrochlorothiazide16$190$12
Glipizide13$180$14
Alendronate15$143$10
Metoprolol13$106$8

2018: 16 drugs

Part D drugs prescribed in 2018
Atorvastatin88$1,966$22
Losartan74$1,257$17
Levothyroxine26$780$30
Amlodipine Besylate57$460$8
Metformin37$411$11
Lactulose16$332$21
Fluticasone Propionate25$319$13
Atenolol23$305$13
Terazosin18$301$17
Hydrochlorothiazide23$296$13
Lisinopril26$286$11
Metoprolol27$255$9
Alendronate19$240$13
Lovastatin13$198$15
Simvastatin14$156$11
Azithromycin11$93$8

2017: 16 drugs

Part D drugs prescribed in 2017
Androderm12$5,565$464
Atorvastatin69$1,695$25
Losartan55$1,334$24
Levothyroxine19$582$31
Atenolol23$292$13
Lisinopril25$274$11
Metformin25$258$10
Amlodipine Besylate29$245$8
Fluticasone Propionate15$196$13
Metoprolol18$179$10
Lovastatin11$175$16
Terazosin13$156$12
Hydrochlorothiazide11$142$13
Lisinopril-Hydrochlorothiazide11$135$12
Lorazepam13$119$9
Azithromycin12$92$8

2016: 2 drugs

Part D drugs prescribed in 2016
Atorvastatin19$490$26
Lisinopril12$134$11

2014: 6 drugs

Part D drugs prescribed in 2014
Spiriva12$6,348$529
Metoprolol16$483$30
Potassium Chloride11$132$12
Amlodipine Besylate17$93$5
Metformin11$73$7
Lisinopril11$61$6

2013: 6 drugs

Part D drugs prescribed in 2013
Metoprolol16$379$24
Metformin21$170$8
Lisinopril22$120$5
Simvastatin11$97$9
Levothyroxine14$95$7
Amlodipine Besylate14$62$4

Money from drug and device companies

$642 in 2025

Industry payments by year
202545None$642
202411None$119

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Otsuka America PharmaceuticalRexulti$250
2 payments
  • Meals for Rexulti · 2025-10-08 · $125
  • Meals for Rexulti · 2025-06-18 · $125
Sanofi-Aventis U.S.Tzield$150
1 payment
  • Meals for Tzield · 2025-03-19 · $150
ViiV HealthcareApretude$125
1 payment
  • Meals for Apretude · 2025-08-20 · $125
Lilly USAKisunla$117
1 payment
  • Meals for Kisunla · 2025-09-17 · $117
See all 5 published payments
Every published payment
Otsuka America PharmaceuticalMeals · 2025-10-08Rexulti$125
Lilly USAMeals · 2025-09-17Kisunla$117
ViiV HealthcareMeals · 2025-08-20Apretude$125
Otsuka America PharmaceuticalMeals · 2025-06-18Rexulti$125
Sanofi-Aventis U.S.Meals · 2025-03-19Tzield$150
See earlier years (2024)

2024: $119

Payments by company in 2024
Gilead SciencesVemlidy$119
1 payment
  • Meals for Vemlidy · 2024-07-12 · $119

Professional record

NPI
1366716391
Licence
CA 132936California A132936: Current · expires 2028-10-31
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Internal medicine (207R00000X)
Mailing address
Po Box 276950, Sacramento, CA, 95827
NPI first listed
2012-03-08
NPI last updated
2025-01-09
NPI record certified
2025-01-09

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.